Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€17.90

€17.90

3.470%
0.6
3.470%
-
 
26.04.24 / Stuttgart Stock Exchange WKN: A2N9MM / Name: Marinomed Biotech / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Marinomed Biotech AG Stock

A very strong showing by Marinomed Biotech AG today, with an increase of €0.60 (3.470%) compared to yesterday's price.
So far the community has only identified positive things for Marinomed Biotech AG stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Marinomed Biotech AG in the next few years

Pros
?
S********** s********
?
B****
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

News

EQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
EQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
EQS-News: Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
EQS-News: Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
EQS-News: Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
EQS-News: Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
EQS-News: Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico
EQS-News: Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico
EQS-News: Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico